Verastem Inc (VSTM)
10.26
-0.57
(-5.30%)
USD |
NASDAQ |
Apr 18, 16:00
10.26
0.00 (0.00%)
After-Hours: 20:00
Verastem Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2022 | 3.643M |
| December 31, 2021 | 2.053M |
| September 30, 2021 | 2.014M |
| June 30, 2021 | 80.66M |
| March 31, 2021 | 84.47M |
| December 31, 2020 | 88.52M |
| September 30, 2020 | 91.63M |
| Date | Value |
|---|---|
| June 30, 2020 | 22.01M |
| March 31, 2020 | 20.84M |
| December 31, 2019 | 17.46M |
| September 30, 2019 | 15.05M |
| June 30, 2019 | 21.52M |
| March 31, 2019 | 28.39M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.014M
Minimum
Sep 2021
91.63M
Maximum
Sep 2020
37.49M
Average
21.18M
Median
Revenue (TTM) Benchmarks
| Amgen Inc | 28.19B |
| Johnson & Johnson | 93.02B |
| Ampio Pharmaceuticals Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |